XTLB - XTL Biopharmaceuticals Ltd.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
0.0032
(+3.00%)
Recent News
- XTL Biopharma plunges on Bicifadine trial failure
Nov 18, 11:23 AM EST - (AP) - XTL Biopharma downgraded by Ladenburg Thalmann
Nov 18, 9:45 AM EST - (Briefing.com) - UPDATE - XTL's diabetic pain drug fails in trial, shares sink
Nov 18, 8:50 AM EST - (at Reuters) - XTL Biopharmaceuticals Announces Top-Line Results From the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain
Nov 18, 8:05 AM EST - (PR Newswire) - Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
Oct 10, 2:00 PM EDT - (PR Newswire) - Click Here To See More News...
Open a Brokerage Account and Start Trading Today!
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com
Copyright © 2008 Stock Market eNews, Inc. All rights reserved.
Financial Market Data powered by QuoteMedia, Inc.
NYSE/AMEX data delayed 20 minutes.
NASDAQ and other data delayed 15 minutes unless indicated.
Views express in blog articles and forums are not necessarily those of Stock Market eNews, Inc.
If you feel some content to be inappropriate, please let us know and we will take care of it immediately.